IRF8 is a transcriptional activator of CD37 expression in diffuse large B-cell lymphoma.
Elfrink S, Ter Beest M, Janssen L, Baltissen MP, Jansen PWTC, Kenyon AN, Steen RM, de Windt D, Hagemann PM, Hess C, van Spronsen DJ, Hoevenaars B, van der Spek E, Xu-Monette ZY, Young KH, Kaffa C, Bervoets S, van Heek J, Hesius E, de Winde CM, Vermeulen M, van den Brand M, Scheijen B, van Spriel AB.
Elfrink S, et al. Among authors: kaffa c.
Blood Adv. 2022 Apr 12;6(7):2254-2266. doi: 10.1182/bloodadvances.2021004366.
Blood Adv. 2022.
PMID: 35086136
Free PMC article.